IP Library Granted Patent US 12,473,442
Granted Patent B2
US 12,473,442 · App. 17/020,345 · Granted Nov 18, 2025

Preparation and applications of biocompatible conductive 3D hydrogels based on cellulose nanofibrils for diagnostics and intervention of neurodegenerative and cardiac diseases

Inventors: Paul Gatenholm (Riner, VA); Erdem Karabulut (Oslo, NO)
Assignee: Ocean Tunicell AS
C09D11/14A61L27/08A61L27/20A61L27/36A61L27/3625A61L27/367A61L27/3675A61L27/3691A61L27/38A61L27/3826A61L27/383A61L27/3834A61L27/3873A61L27/3895A61L27/443A61L27/50A61N1/0536A61N1/3605A61N1/36067A61N1/36082A61N1/362B33Y70/00B33Y80/00C09D4/00C09D7/67C09D11/03C09D11/037C09D11/30C09D11/324C09D11/38C09D11/52C12N5/0062C12N5/0619C12N5/0657C12N5/0691C12N5/0693C12N5/0697A61L2300/412A61L2300/64A61L2400/12A61L2430/20A61L2430/32B82Y30/00C12N2501/90C12N2501/999C12N2513/00C12N2533/78C12N2539/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,473,442
App. No.
17/020,345
Granted
Nov 18, 2025
Kind
B2
Abstract

The present invention relates to preparation and use of biocompatible and electrically conductive 3D hydrogels comprising nanocellulose fibrils, such as disintegrated bacterial nanocellulose, plant derived nanocellulose, tunicate derived nanocellulose, or algae derived nanocellulose, together with carbon nanotubes or graphene oxide, as a biocompatible and conductive 3D hydrogel for diagnostics and intervention to mimic or restore tissue and organ function. Biocompatible conductive 3D hydrogels described in this invention can be extruded, casted or injected. The 3D hydrogels described in this invention are cohesive 3D structures and provide electrical conductivity in wet form. 3D hydrogels described in this invention can be further crosslinked using divalent ions such as Calcium ions which improve mechanical stability. Such crosslinking can take place in an animal or human body in a physiological environment after injection into the tissue. 3D hydrogels are biocompatible and show preferable mechanical properties and electrical conductivity through printed lines (4.10 −1 S cm −1 ). The 3D hydrogels prepared by this invention are suited as bioassays to screen drugs against neurodegenerative diseases such as Alzheimer's and Parkinson's, study brain function, and/or be used to link the human brain with electronic and/or communication devices. They can also be injected to replace neural tissue or stimulate guiding of neural cells. They can also be used to inject into the heart and stimulate the heart by using electrical signaling or to repair myocardial infarction.

Claims (7)

1 . A biocompatible and electrically conductive three-dimensional (3D) hydrogel comprising nanocellulose, wherein the 3D hydrogel in its final form for bioprinting or injecting into tissue is non-dried, wherein the nanocellulose comprises one or more of bacterial cellulose, cellulose nanofibrils, cellulose nanocrystals, or disintegrated bacterial cellulose, wherein the nanocellulose is isolated from tunicates, bacteria, plants, and/or algae, wherein the non-dried 3D hydrogel further comprises graphitic-based electrically conductive nanomaterials, and wherein the non-dried 3D hydrogel in its final form is bioprinted to form three-dimensionally bioprinted structures or injected into tissue.

2 . The biocompatible and electrically conductive 3D hydrogel of claim 1 , wherein all or some of the nanocellulose is negatively charged.

3 . The biocompatible and electrically conductive 3D hydrogel of claim 2 , wherein the nanocellulose is negatively charged by TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl radical) oxidation, periodate oxidation followed by reduction, carboxymethylation, or combinations thereof.

4 . The biocompatible and electrically conductive 3D hydrogel of claim 1 , wherein sodium potassium or quaternary ammonium salts of carboxymethylcellulose (CMC) is added to the nanocellulose.

5 . The biocompatible and electrically conductive 3D hydrogel of claim 1 , wherein the graphitic-based electrically conductive nanomaterials are negatively charged.

6 . The biocompatible and electrically conductive 3D hydrogel of claim 1 , wherein the graphitic-based electrically conductive nanomaterials include one or more carbon nanotubes, graphene oxide, or both.

7 . The biocompatible and electrically conductive 3D hydrogel of claim 6 , wherein the one or more carbon nanotubes, the graphene oxide, or both, are negatively charged.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2020
From: CELLHEAL AS
To: OCEAN TUNICELL AS
Reel/Frame 054592/0059 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: GATENHOLM, PAUL; KARABULUT, ERDEM
To: CELLHEAL AS
Reel/Frame 053764/0473 →
Continuity (3)
Continuation 15963076 · Apr 25, 2018
Provisional Application 62489653 · Apr 25, 2017
Related Publication 20200407577A1 · Dec 31, 2020
References Cited (8)
US 20130171439A1 · Shoseyov et al. · 2013 [cited by applicant]
US 20140058077A1 · Laukkanen · 2014 [cited by examiner]
US 20160297104A1 · Guillemette · 2016 [cited by examiner]
Zheng et al. (ACS Appl. Mater. Interfaces 2015;7:3263-3271). (Year: 2015). [cited by applicant]
Ougiya et al. (Biosci. Biotechnol. Biochem. 1998;62(9):1714-1719). (Year: 1998). [cited by applicant]
Zhao et al. (ACS Appl. Mater. Interfaces Mar. 28, 2017;9:13508-13519). (Year: 2017). [cited by applicant]
Hoeng et al. (RSC Adv. Mar. 7, 2017;7:15372-15381). (Year: 2017). [cited by applicant]
Related Case U.S. Appl. No. 16/608,714, Office Action dated Aug. 22, 2022. [cited by applicant]